# Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia

> **NCT05785377** · NA · NOT_YET_RECRUITING · sponsor: **Mansoura University** · enrollment: 58 (estimated)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Bupivacaine-Neostigmine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT05785377
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-12-01
- **Primary completion:** 2029-07-30
- **Final completion:** 2029-12-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05785377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05785377, "Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05785377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*